[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
From The Medical Letter on Drugs and Therapeutics
October 15, 2014

Drugs for MRSA Skin and Soft-Tissue Infections

JAMA. 2014;312(15):1583-1584. doi:10.1001/jama.2014.13385

Methicillin-resistant Staphylococcus aureus (MRSA), which was traditionally a nosocomially-acquired organism but now frequently occurs in the absence of health care exposure, is the predominant cause of suppurative skin and soft-tissue infections in many parts of the US.1,2 Community-associated MRSA usually causes furunculosis, purulent cellulitis, and abscesses, but necrotizing fasciitis, necrotizing pneumonia, and sepsis can also occur.

First Page Preview View Large
First page PDF preview
First page PDF preview
×